Parametrica Management’s Amedisys AMED Stock Holding History

Parametrica Management’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-2,789	Closed	-$349K	–	261
2018 Q3	$349K	Buy	+2,789	New	+$308K	0.76%	34

Other funds holding AMED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Parametrica Management's AMED Position: Q4 2018 in Review

Parametrica Management sold out of Amedisys (AMED) in Q4 2018, closing a stake of 2,789 shares — an estimated $349K sold.

Parametrica Management first reported a position in AMED in Q3 2018 and held it in 1 quarter. The position peaked at $349K in Q3 2018. 297 funds tracked by Wall St. Rank hold AMED as of Q4 2018.

Parametrica Management reported no remaining Amedisys position as of Q4 2018 after selling out during the quarter.
Parametrica Management sold 2,789 Amedisys shares in Q4 2018, an estimated $349K.
Parametrica Management first reported a position in Amedisys in Q3 2018 and held it in 1 quarter.
Parametrica Management's Amedisys position peaked at $349K in Q3 2018.
297 funds tracked by Wall St. Rank held Amedisys as of Q4 2018.

Based on Parametrica Management's 13F filing for Q4 2018, filed 12 Feb 2019.